Inspiratory muscle training prior to peripheral muscle training in children and adolescents with Cystic Fibrosis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20853

Enrollment

Registered

2009-11-04

Start date

2009-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inspiratory muscles (inademhaling spieren) training Cystic Fibrosis (taaislijmziekte) exercise capacity (inspanningsvermogen)

Interventions

Both groups receive inspiratory muscle training (IMT) or sham (placebo)-IMT based on randomization. IMT last for 6 weeks, 5 days a week, 11 minutes a day. After IMT or sham-IMT, both groups receive a

Eligibility

Inclusion criteria

Inclusion criteria: 1. Ambulant patients with CF; 2. Age: range from 12 to 18 years of age.

Exclusion criteria

Exclusion criteria: 1. Gastro-intestinal or pulmonary exacerbation (extra oral or intravenous antibiotics for the past four weeks) at inclusion; 2. Oxygen saturation (SpO2) < 90% (without O2 supply); 3. Ineligible to perform CPET; 4. Not familiar with the Dutch language; 5. Pneumothorax; 6. Participation in study “MOVIT” less than one year ago. Patients can enter the protocol one year after finishing participation in “MOVIT”.

Design outcomes

Primary

Measure	Time frame
Peak workload attained during cardiopulmonary exercise testing.	—

Secondary

Measure	Time frame
1. Exercise capacity; 2. Respiratory muscle function; 3. Peripheral muscle function; 4. Habitual daily activity; 5. Rate of perceived excertion; 6. Patients preferred ocupational performance; 7. Spirometry; 8. Anthropometry; 9. Use of medication and other care; 10. Health related quality of life.	—

Contacts

Public ContactH.J. Hulzebos

PO Box 85090

H.Hulzebos@umcutrecht.nl+31 (0)88 7554030

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)